Immunic
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunic and other ETFs, options, and stocks.About IMUX
Immunic, Inc. is a clinical-stage biopharmaceutical company, which develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn’s disease, relapsing-remitting multiple sclerosis, and psoriasis.
IMUX Key Statistics
Stock Snapshot
As of today, Immunic(IMUX) shares are valued at $15.07. The company's market cap stands at 201.46M, with a P/E ratio of -2.45.
During the trading session on 2026-07-09, Immunic(IMUX) shares reached a daily high of $15.40 and a low of $14.61. At a current price of $15.07, the stock is +3.1% higher than the low and still -2.1% under the high.
Trading activity shows a volume of 122.19K, compared to an average daily volume of 182.39K.
The stock's 52-week range extends from a low of $5.06 to a high of $15.84.
The stock's 52-week range extends from a low of $5.06 to a high of $15.84.
IMUX News
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.